Oct 20, 2026 04:00PM
Aug 6, 2026 07:01AM
Jun 29, 2026 12:25PM
Jun 29, 2026 09:50AM
Jun 29, 2026 09:28AM
Jun 29, 2026 07:09AM
Jun 29, 2026 04:47AM Viridian Therapeutic (VRDN) Reiterated at Market Outperform by Citizens: Lumvoa Approved
Jun 26, 2026 06:00PM
Jun 26, 2026 06:00PM
May 29, 2026 12:07PM
May 5, 2026 07:01AM
May 5, 2026 07:00AM
May 5, 2026 07:00AM
Mar 30, 2026 07:02AM Viridian says elegrobart meets primary goal in thyroid eye disease trial
Mar 30, 2026 07:01AM
Feb 26, 2026 07:01AM
Jan 7, 2026 01:03AM
Jan 6, 2026 07:02AM
Jan 6, 2026 07:01AM
Dec 22, 2025 07:01AM
Dec 22, 2025 07:00AM Viridian Therapeutics Announces BLA Acceptance and Priority Review for Veligrotug for the Treatment of Thyroid Eye Disease
Dec 19, 2025 09:06AM
Dec 18, 2025 03:57AM
Nov 6, 2025 04:26AM
Nov 5, 2025 07:01AM
Nov 3, 2025 08:34AM
Nov 3, 2025 07:01AM
Oct 21, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Viridian Therapeutic (VRDN)
Oct 20, 2025 07:30AM
Sep 15, 2025 07:02AM
Sep 15, 2025 07:01AM
Aug 6, 2025 06:30AM
May 20, 2025 07:01AM
May 20, 2025 07:00AM
May 7, 2025 04:31PM Viridian Therapeutics (VRDN) Receives FDA Breakthrough Therapy Designation for Veligrotug for the Treatment of Thyroid Eye Disease
May 7, 2025 04:15PM
May 6, 2025 07:00AM
Aug 14, 2024 03:58PM
Jun 11, 2024 06:00AM
May 9, 2024 06:55AM
May 9, 2024 06:55AM
May 8, 2024 07:00AM Viridian Therapeutics Highlights Recent Progress and Reports First Quarter 2024 Financial Results
Jul 10, 2023 04:01PM
Jul 10, 2023 04:01PM
May 9, 2023 04:01PM
Mar 8, 2023 07:00AM
Nov 30, 2022 10:39AM
Nov 30, 2022 09:34AM
Nov 14, 2022 06:59AM Viridian Therapeutics (VRDN) Reports Positive Data from Ongoing Phase 1/2 Trial of VRDN-001
Nov 14, 2022 06:59AM

335,202 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All